| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.03 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |